Characterizing the Coding Region Determinant-Binding Protein (CRD-BP)-Microphthalmia-associated Transcription Factor...

Area of Science:

• Molecular Biology
• RNA-Protein Interactions
• Cancer Biology

Background:

• Coding region determinant-binding protein (CRD-BP) stabilizes microphthalmia-associated transcription factor (MITF) mRNA against miR-340 degradation.
• Understanding the CRD-BP and MITF RNA interaction is crucial for deciphering CRD-BP's oncogenic role.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying the CRD-BP and MITF RNA interaction.
• To identify specific binding sites and develop inhibitors of this interaction.

Main Methods:

• Point mutations in CRD-BP's KH domains to assess binding.
• RNA fragment mapping to determine the minimal MITF RNA binding site.
• Antisense oligonucleotide design and evaluation.
• RNase protection and fluorescence polarization assays.

Main Results:

• All four KH domains of CRD-BP are essential for MITF RNA binding.
• The 49-nt fragment (nts 1621-1669) of MITF 3'-UTR is the minimal binding site.
• Antisense oligonucleotides MHO-1 and MHO-7 potently inhibit CRD-BP-MITF RNA interaction by directly binding MITF RNA.

Conclusions:

• CRD-BP interacts with MITF RNA via its KH domains, with a critical binding site in the 49-nt fragment.
• MHO-1 and MHO-7 are effective inhibitors of this interaction, potentially useful for therapeutic development.
• These findings provide molecular insights into CRD-BP's oncogenic function and potential therapeutic targets.